The incidence of pediatric inflammatory bowel disease (IBD) is increasing worldwide, especially in the developing countries. It differs from adult disease in clinical manifestations, especially with regard to genetic predisposition in monogenic IBD. Pediatric disease also have a tendency to show more aggressive inflammation and greater extent of lesion. Newer drugs such as antitumor necrosis factor-α have been known to make a difference in treating pediatric IBD. Recent studies suggested that the patients with high risk factors might have some benefits from earlier use of biologics. To achieve treatment goals such as relieving symptoms, optimizing growth, and improving quality of life while minimizing drug toxicity, more research is needed to develop tools for risk stratification in the use of biologics for pediatric IBD.
Citations
Citations to this article as recorded by
Noninvasive monitoring with bowel ultrasound (NIMBUS) in paediatric inflammatory bowel disease: Feasibility in a single centre Zachary Green, Christopher Towriss, James J. Ashton, R. Mark Beattie, Alison Evans, Amar Wahid, Martin Edwards Journal of Pediatric Gastroenterology and Nutrition.2025; 81(4): 1014. CrossRef
Constitutive Androstane Receptor Agonist, TCPOBOP: Maternal Exposure Impairs the Growth and Development of Female Offspring in Mice Shijia Pan, Yuan Guo, Wen Yu, Jia Zhang, Xiaoxiao Qiao, Letong Li, Pengfei Xu, Yonggong Zhai International Journal of Molecular Sciences.2023; 24(3): 2602. CrossRef
Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease Mahmoud H. Mosli, Hajer Y. Almudaiheem, Turki AlAmeel, Shakir A. Bakkari, Othman R. Alharbi, Khalidah A. Alenzi, Amr M. Khardaly, Maha A. AlMolaiki, Bedor A. Al-Omari, Rayan G. Albarakati, Ahmed H. Al-Jedai, Omar I. Saadah, Majid A. Almadi, Badr Al-Baward Saudi Journal of Gastroenterology.2023; 29(Suppl 1): S1. CrossRef
Lactic Acid Bacteria Isolated from Human Breast Milk Improve Colitis Induced by 2,4,6-Trinitrobenzene Sulfonic Acid by Inhibiting NF-κB Signaling in Mice Kyung-Joo Kim, Suhyun Kyung, Hui Jin, Minju Im, Jae-won Kim, Hyun Su Kim, Se-Eun Jang Journal of Microbiology and Biotechnology.2023; 33(8): 1057. CrossRef
NIMBUS study protocol: a single-centre feasibility study of non-invasive monitoring with bowel ultrasound in paediatric inflammatory bowel disease Zachary Green, Ella Mayberry, James John Ashton, R Mark Beattie, Alison Evans, Amar Wahid, Martin Oliver Edwards BMJ Open.2023; 13(12): e078675. CrossRef
Clinical Characteristics and Long-term Outcomes of Pediatric Ulcerative Colitis: A Single-Center Experience in Korea Jooyoung Jang, Sung Hee Lee, In Sook Jeong, Jinmin Cho, Hyun Jin Kim, Seak Hee Oh, Dae Yeon Kim, Ho-Su Lee, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Kyung Mo Kim Gut and Liver.2022; 16(2): 236. CrossRef
Phenotypic Pattern of Early Versus Later‐Onset Pediatric Inflammatory Bowel Disease in a Eurasian Country Bilge S. Akkelle, Deniz Ertem, Burcu Volkan, Engin Tutar Journal of Pediatric Gastroenterology and Nutrition.2022;[Epub] CrossRef
Xi Lei San Attenuates Dextran Sulfate Sodium‐Induced Colitis in Rats and TNF‐α‐Stimulated Colitis in CACO2 Cells: Involvement of the NLRP3 Inflammasome and Autophagy Zhang Tao, Xiaoqing Zhou, Yan Zhang, Wenfeng Pu, Yi Yang, Fuxia Wei, Qian Zhou, Lin Zhang, Zhonghan Du, Ji Wu, Francesco Giudici Mediators of Inflammation.2021;[Epub] CrossRef
Epidemiology and diagnosis of inflammatory bowel diseases Kang-Moon Lee Journal of the Korean Medical Association.2021; 64(9): 579. CrossRef
Current status of inflammatory bowel diseases in Korea Suk-Kyun Yang Journal of the Korean Medical Association.2021; 64(9): 572. CrossRef
Transition Services for Pediatric Inflammatory Bowel Disease Suk‐Kyun Yang, Sang Hyoung Park, Byong Duk Ye Journal of Pediatric Gastroenterology and Nutrition.2021;[Epub] CrossRef
Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease Rupa Banerjee, Partha Pal, Zaheer Nabi, Upender Shava, Girish Ganesh, D. Nageshwar Reddy Intestinal Research.2021; 19(4): 398. CrossRef
Another Piece of Evidence for Early Administration of Biologics in Children with Crohn's Disease Who Start as an Inflammatory Phenotype Hyuk Yoon Gut and Liver.2021; 15(6): 791. CrossRef
Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea Hyun Jin Kim, Seak Hee Oh, Sung Hee Lee, Yu-Bin Kim, Dae Yeon Kim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Kyung Mo Kim Gut and Liver.2021; 15(6): 851. CrossRef
Repeatability of Magnetic Resonance Measurements Used for Estimating Crohn’s Disease Activity Ilze Apine, Ieva Pirksta, Reinis Pitura, Juris Pokrotnieks, Ieva Puķīte, Gaida Krūmiņa Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences..2020; 74(2): 75. CrossRef